Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Anticancer Research
  • Other Publications
    • Anticancer Research
    • In Vivo
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Anticancer Research

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Editorial Policies
    • Subscribers
    • Advertisers
    • Editorial Board
    • Special Issues 2025
  • Journal Metrics
  • Other Publications
    • In Vivo
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
    • 2008 Nobel Laureates
  • About Us
    • General Policy
    • Contact
  • Visit us on Facebook
  • Follow us on Linkedin
Research ArticleClinical Studies

Real-world Outcomes in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck With Nivolumab: Galician Study

LETICIA IGLESIAS, ROCÍO VÍLCHEZ, SANTIAGO AGUÍN, RAMÓN GARCÍA, CAROLINA PENA, ALBERTO CARRAL, GERARDO HUIDOBRO, AUREA MOLINA, JESÚS GARCÍA GÓMEZ, MARTA COVELA, MARINHA COSTA and ANA MEDINA
Anticancer Research March 2025, 45 (3) 1181-1191; DOI: https://doi.org/10.21873/anticanres.17505
LETICIA IGLESIAS
1Department of Medical Oncology, Complejo Hospitalario Universitario de Ourense (CHUO), Ourense, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: leticia.iglesias.rey@sergas.es
ROCÍO VÍLCHEZ
2Department of Medical Oncology, Complejo Hospitalario Universitario de Ferrol (CHUF), A Coruña, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
SANTIAGO AGUÍN
3Department of Medical Oncology, Complejo Hospitalario Universitario de Santiago de Compostela (CHUS), A Coruña, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
RAMÓN GARCÍA
4Department of Medical Oncology, Complejo Hospitalario Universitario de Pontevedra (CHOP), Pontevedra, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
CAROLINA PENA
5Department of Medical Oncology, Fundación Centro Oncológico de Galicia (COG), A Coruña, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ALBERTO CARRAL
6Department of Medical Oncology, Hospital Universitario Lucus Augusti (HULA), Lugo, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
GERARDO HUIDOBRO
7Department of Medical Oncology, Complejo Hospitalario Universitario de Vigo (CHUVI), Pontevedra, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
AUREA MOLINA
8Department of Medical Oncology, Complejo Universitario de A Coruña (CHUAC), A Coruña, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
JESÚS GARCÍA GÓMEZ
1Department of Medical Oncology, Complejo Hospitalario Universitario de Ourense (CHUO), Ourense, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARTA COVELA
6Department of Medical Oncology, Hospital Universitario Lucus Augusti (HULA), Lugo, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
MARINHA COSTA
9Department of Medical Oncology, Hospital Ribera POVISA, Pontevedra, Spain
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
ANA MEDINA
5Department of Medical Oncology, Fundación Centro Oncológico de Galicia (COG), A Coruña, Spain;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.

Log in using your username and password

Forgot your user name or password?

Purchase access

You may purchase access to this article. This will require you to create an account if you don't already have one.

patientACCESS

patientACCESS - Patients desiring access to articles
PreviousNext
Back to top

In this issue

Anticancer Research: 45 (3)
Anticancer Research
Vol. 45, Issue 3
March 2025
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
  • Back Matter (PDF)
  • Ed Board (PDF)
  • Front Matter (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Anticancer Research.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Real-world Outcomes in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck With Nivolumab: Galician Study
(Your Name) has sent you a message from Anticancer Research
(Your Name) thought you would like to see the Anticancer Research web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
4 + 6 =
Solve this simple math problem and enter the result. E.g. for 1+3, enter 4.
Citation Tools
Real-world Outcomes in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck With Nivolumab: Galician Study
LETICIA IGLESIAS, ROCÍO VÍLCHEZ, SANTIAGO AGUÍN, RAMÓN GARCÍA, CAROLINA PENA, ALBERTO CARRAL, GERARDO HUIDOBRO, AUREA MOLINA, JESÚS GARCÍA GÓMEZ, MARTA COVELA, MARINHA COSTA, ANA MEDINA
Anticancer Research Mar 2025, 45 (3) 1181-1191; DOI: 10.21873/anticanres.17505

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Reprints and Permissions
Share
Real-world Outcomes in Recurrent/Metastatic Squamous Cell Carcinoma of Head and Neck With Nivolumab: Galician Study
LETICIA IGLESIAS, ROCÍO VÍLCHEZ, SANTIAGO AGUÍN, RAMÓN GARCÍA, CAROLINA PENA, ALBERTO CARRAL, GERARDO HUIDOBRO, AUREA MOLINA, JESÚS GARCÍA GÓMEZ, MARTA COVELA, MARINHA COSTA, ANA MEDINA
Anticancer Research Mar 2025, 45 (3) 1181-1191; DOI: 10.21873/anticanres.17505
Twitter logo Facebook logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Introduction
    • Patients and Methods
    • Results
    • Discussion
    • Conclusion
    • Acknowledgements
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

  • Prediction of Severe Anemia and Neutropenia Induced by Abemaciclib in Patients With Breast Cancer
  • Impact of Nivolumab Plus Chemotherapy on Conversion Therapy in Clinical Stage IVB HER2-negative Gastric Cancer
  • Treatment Outcomes After Progression With Enfortumab Vedotin in Patients With Advanced Urothelial Carcinoma
Show more Clinical Studies

Similar Articles

Keywords

  • nivolumab
  • recurrent or metastatic disease
  • squamous cell carcinoma of the head and neck
  • real-life data
  • adverse events
Anticancer Research

© 2025 Anticancer Research

Powered by HighWire